EUVIMEDEUVIMED entdecken
Crossref

Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures

Wenjie Jiang, Fan Zhang, Zhen Tang, Shuonan Xu, Yukun Zhang, Lina Liu, Daixing Zhong, Yingxiang Liu

International Journal of Clinical Oncology · 2025

DOI: 10.1007/s10147-024-02664-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Wenjie Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Tangdu Hospital, the Air Force Medical University, Xi'an, 710038, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Mitophagy, Lung Neoplasms, Lactic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Xi'an People's Hospital (Xi'an Fourth Hospital) scientific research incubation fund, National Natural Science Foundation of China, "Phoenix Introduction Plan" Talent Startover Project of Tangdu Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungMitophagyLung NeoplasmsLactic AcidBiomarkers, TumorHumansPrognosisNomogramsGene Expression Regulation, NeoplasticFemaleMale

Stichwörter der Autor:innen

Immune microenvironmentLactateLung adenocarcinomaMitophagyNomogram

Substanzen

Lactic AcidBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Tangdu Hospital, the Air Force Medical University, Xi'an, 710038, China.
  • Department of Thoracic Surgery, Weinan Central Hospital, Weinan, 714000, China.
  • Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an, China.
  • Department of Orthopedic Surgery, Orthopedic Oncology Institute, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
  • Department of Cardiology, Tangdu Hospital, The Air Force Medical University, Xi'an 710038, China.
  • Department of Clinical Laboratory, Xi'an Peoples' Hospital (Xi'an Fourth Hospital), Xi'an, 710004, Shaanxi, China. liulinawei@163.com.

Förderung

  • Xi'an People's Hospital (Xi'an Fourth Hospital) scientific research incubation fund
  • National Natural Science Foundation of China
  • "Phoenix Introduction Plan" Talent Startover Project of Tangdu Hospital
  • Xi’an People's Hospital (Xi’an Fourth Hospital) scientific research incubation fund
  • “Phoenix Introduction Plan” Talent Startover Project of Tangdu Hospital

Zitieren

APA

Jiang, W., Zhang, F., Tang, Z., Xu, S., Zhang, Y., Liu, L., Zhong, D., & Liu, Y. (2025). Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02664-3

Vancouver

Jiang W, Zhang F, Tang Z, Xu S, Zhang Y, Liu L, et al. Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-024-02664-3

BibTeX
@article{Jiang2025,
  author = {Jiang, Wenjie and Zhang, Fan and Tang, Zhen and Xu, Shuonan and Zhang, Yukun and Liu, Lina and Zhong, Daixing and Liu, Yingxiang},
  title = {Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures},
  journal = {International Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1007/s10147-024-02664-3}
}
Kostenlos starten →